{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T07:10:16Z","timestamp":1772781016656,"version":"3.50.1"},"reference-count":65,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2016,9,21]],"date-time":"2016-09-21T00:00:00Z","timestamp":1474416000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Pharmaceutical Biology"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1080\/13880209.2016.1225778","type":"journal-article","created":{"date-parts":[[2016,9,21]],"date-time":"2016-09-21T11:41:24Z","timestamp":1474458084000},"page":"19-32","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":30,"title":["<i>In silico<\/i>\n            identification of promiscuous scaffolds as potential inhibitors of 1-deoxy-\n            <scp>d<\/scp>\n            -xylulose 5-phosphate reductoisomerase for treatment of\n            <i>Falciparum<\/i>\n            malaria"],"prefix":"10.1080","volume":"55","author":[{"given":"Abdul","family":"Wadood","sequence":"first","affiliation":[{"name":"Department of Biochemistry, Abdul Wali Khan University Mardan, Mardan, Pakistan;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehreen","family":"Ghufran","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Abdul Wali Khan University Mardan, Mardan, Pakistan;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Syed Fahad","family":"Hassan","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, University of Lahore, Lahore, Pakistan;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huma","family":"Khan","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Abdul Wali Khan University Mardan, Mardan, Pakistan;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Syed Sikandar","family":"Azam","sequence":"additional","affiliation":[{"name":"Department of Bioinformatics, Quaid-i-Azam University, Islamabad, Pakistan;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Umer","family":"Rashid","sequence":"additional","affiliation":[{"name":"Department of Chemistry, COMSAT, Abbatabad, Pakistan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2016,9,21]]},"reference":[{"key":"e_1_3_2_2_1","doi-asserted-by":"publisher","DOI":"10.1586\/ecp.09.28"},{"key":"e_1_3_2_3_1","first-page":"329","article-title":"Tools for discovery of inhibitors of the 1-deoxy-D-xylulose 5-phosphate (DXP) synthase and DXP reductoisomerase: an approach with enzymes from the pathogenic bacterium Pseudomonas aeruginosa.","volume":"190","author":"Altincicek B","year":"2000","unstructured":"Altincicek B, Hintz M, Sanderbrand S, Wiesner J, Beck E, Jomaa H. 2000. Tools for discovery of inhibitors of the 1-deoxy-D-xylulose 5-phosphate (DXP) synthase and DXP reductoisomerase: an approach with enzymes from the pathogenic bacterium Pseudomonas aeruginosa. FEMS Microbiol Lett. 190:329\u2013333.","journal-title":"FEMS Microbiol Lett"},{"key":"e_1_3_2_4_1","doi-asserted-by":"publisher","DOI":"10.1002\/med.2610020404"},{"key":"e_1_3_2_5_1","doi-asserted-by":"publisher","DOI":"10.1038\/srep26773"},{"key":"e_1_3_2_6_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M110.162081"},{"key":"e_1_3_2_7_1","doi-asserted-by":"publisher","DOI":"10.1097\/00000539-200012000-00038"},{"key":"e_1_3_2_8_1","doi-asserted-by":"publisher","DOI":"10.1039\/9781849731102-00275"},{"key":"e_1_3_2_9_1","first-page":"286","article-title":"Influence of aromatic rings on ADME properties of drugs. Metabolism, pharmacokinetics and toxicity of functional groups: impact of chemical building blocks on ADMET.","volume":"1","author":"Deepak DD","year":"2010","unstructured":"Deepak DD, Sajiv N, Ping K, Cho-Ming L. 2010. Influence of aromatic rings on ADME properties of drugs. Metabolism, pharmacokinetics and toxicity of functional groups: impact of chemical building blocks on ADMET. R Soc Chem. 1:286\u2013287.","journal-title":"R Soc Chem"},{"key":"e_1_3_2_10_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm200363d"},{"key":"e_1_3_2_11_1","doi-asserted-by":"publisher","DOI":"10.1021\/mp060011k"},{"key":"e_1_3_2_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.molstruc.2007.01.023"},{"key":"e_1_3_2_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2007.12.001"},{"key":"e_1_3_2_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmgm.2013.09.002"},{"key":"e_1_3_2_15_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm201136z"},{"key":"e_1_3_2_16_1","unstructured":"Molinspiration: 2012. Available from: http:\/\/www.molinspiration.com\/"},{"key":"e_1_3_2_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2011.03.008"},{"key":"e_1_3_2_18_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm4006498"},{"key":"e_1_3_2_19_1","doi-asserted-by":"publisher","DOI":"10.1038\/nbt1284"},{"key":"e_1_3_2_20_1","first-page":"479","article-title":"Synthesis of biologically active O-substituted derivatives of 1- [(3, 5-dichloro-2-hydroxyphenyl)sulfonyl]piperidine.","volume":"26","author":"Khalid H","year":"2013","unstructured":"Khalid H, Rehman AU, Abbasi MA, Khan KM, Ashraf M, Ahmad I, Ejaz SA. 2013. Synthesis of biologically active O-substituted derivatives of 1- [(3, 5-dichloro-2-hydroxyphenyl)sulfonyl]piperidine. Pak J Pharm Sci. 26:479\u2013485.","journal-title":"Pak J Pharm Sci"},{"key":"e_1_3_2_21_1","first-page":"515","article-title":"Fosmidomycin: a new phosphonic acid antibiotic. Part I: phase I tolerance studies.","volume":"23","author":"Kuemmerle HP","year":"1985","unstructured":"Kuemmerle HP, Murakawa T, Soneoka K, Konishi T. 1985. Fosmidomycin: a new phosphonic acid antibiotic. Part I: phase I tolerance studies. Int J Clin Pharmacol Ther Toxicol. 23:515\u2013520.","journal-title":"Int J Clin Pharmacol Ther Toxicol"},{"key":"e_1_3_2_22_1","doi-asserted-by":"publisher","DOI":"10.1002\/ardp.200700107"},{"key":"e_1_3_2_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(91)90385-I"},{"key":"e_1_3_2_24_1","doi-asserted-by":"publisher","DOI":"10.1002\/jcc.20933"},{"key":"e_1_3_2_25_1","doi-asserted-by":"publisher","DOI":"10.1002\/3527609164"},{"key":"e_1_3_2_26_1","doi-asserted-by":"publisher","DOI":"10.1002\/minf.201000022"},{"key":"e_1_3_2_27_1","doi-asserted-by":"publisher","DOI":"10.4155\/fmc.11.34"},{"key":"e_1_3_2_28_1","doi-asserted-by":"publisher","DOI":"10.2174\/09298673113209990001"},{"key":"e_1_3_2_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0169-409X(96)00423-1"},{"key":"e_1_3_2_30_1","unstructured":"Marvin 6.0.0 2013. Available from: http:\/\/www.chemaxon.com"},{"key":"e_1_3_2_31_1","first-page":"1126","volume-title":"Pharmacology: from drug development to gene therapy","author":"Meyers RA.","year":"2008","unstructured":"Meyers RA. 2008. Pharmacology: from drug development to gene therapy. vol. 1. England: Wiley-Blackwell. pp. 1126."},{"key":"e_1_3_2_32_1","unstructured":"Molecular Operating Environment (MOE) Chemical Computing Group Inc. 2014-15. Montreal QC Canada."},{"key":"e_1_3_2_33_1","doi-asserted-by":"publisher","DOI":"10.1002\/med.10041"},{"key":"e_1_3_2_34_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.21.2.224"},{"key":"e_1_3_2_35_1","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2875-6-70"},{"key":"e_1_3_2_36_1","doi-asserted-by":"publisher","DOI":"10.1002\/ardp.200700149"},{"key":"e_1_3_2_37_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-199528030-00005"},{"key":"e_1_3_2_38_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm0205651"},{"key":"e_1_3_2_39_1","first-page":"325","article-title":"Can we discover pharmacological promiscuity early in the drug discovery process?","volume":"17","author":"Peters JU","year":"2012","unstructured":"Peters JU, Hert J, Bissantz C, Hillebrecht A, Gerebtzoff G, Bendels S, Tillier F, Migeon J, Fischer H, Guba W, et\u00a0al. 2012. Can we discover pharmacological promiscuity early in the drug discovery process? Drug Disc. 17:325\u2013335.","journal-title":"Drug Disc"},{"key":"e_1_3_2_40_1","doi-asserted-by":"publisher","DOI":"10.2174\/187152610791163336"},{"key":"e_1_3_2_41_1","first-page":"o832","article-title":"Crystal structure of 2-[4(E)-2,6-bis-(4-chloro-phen-yl)-3-ethyl-piperidin-4-yl-idene]acetamide.","volume":"71","author":"Priya K","year":"2015","unstructured":"Priya K, Saravanan K, Selvanayagam S, Kabilan S. 2015. Crystal structure of 2-[4(E)-2,6-bis-(4-chloro-phen-yl)-3-ethyl-piperidin-4-yl-idene]acetamide. Acta Cryst. 71:o832\u2013o833.","journal-title":"Acta Cryst"},{"key":"e_1_3_2_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2004.08.004"},{"key":"e_1_3_2_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2004.12.024"},{"key":"e_1_3_2_44_1","doi-asserted-by":"publisher","DOI":"10.3390\/molecules20010974"},{"key":"e_1_3_2_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmgm.2013.04.006"},{"key":"e_1_3_2_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jorganchem.2014.05.027"},{"key":"e_1_3_2_47_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.102.23.2836"},{"key":"e_1_3_2_48_1","doi-asserted-by":"publisher","DOI":"10.2174\/138161207780618939"},{"key":"e_1_3_2_49_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1098-1128(199605)16:3<243::AID-MED2>3.0.CO;2-Z"},{"key":"e_1_3_2_50_1","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.2007.77.214"},{"key":"e_1_3_2_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2011.03.035"},{"key":"e_1_3_2_52_1","doi-asserted-by":"publisher","DOI":"10.1038\/srep00009"},{"key":"e_1_3_2_53_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00301-12"},{"key":"e_1_3_2_54_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrd1032"},{"key":"e_1_3_2_55_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1008192010023"},{"key":"e_1_3_2_56_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1747-0285.2011.01281.x"},{"key":"e_1_3_2_57_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0089109"},{"key":"e_1_3_2_58_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmgm.2012.11.010"},{"key":"e_1_3_2_59_1","doi-asserted-by":"publisher","DOI":"10.1248\/cpb.59.1376"},{"key":"e_1_3_2_60_1","doi-asserted-by":"publisher","DOI":"10.1002\/ardp.200700069"},{"key":"e_1_3_2_61_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature07361"},{"key":"e_1_3_2_62_1","unstructured":"Simulations Plus Inc. 2014. Available from: www.simulations-plus.com"},{"key":"e_1_3_2_63_1","doi-asserted-by":"publisher","DOI":"10.1021\/ml300419r"},{"key":"e_1_3_2_64_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm201548z"},{"key":"e_1_3_2_65_1","doi-asserted-by":"publisher","DOI":"10.1038\/nsb921"},{"key":"e_1_3_2_66_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1505584112"}],"container-title":["Pharmaceutical Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/13880209.2016.1225778","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/13880209.2016.1225778","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,4]],"date-time":"2024-07-04T13:16:19Z","timestamp":1720098979000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/13880209.2016.1225778"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,21]]},"references-count":65,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["10.1080\/13880209.2016.1225778"],"URL":"https:\/\/doi.org\/10.1080\/13880209.2016.1225778","relation":{},"ISSN":["1388-0209","1744-5116"],"issn-type":[{"value":"1388-0209","type":"print"},{"value":"1744-5116","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,21]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iphb20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iphb20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2016-03-18","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2016-08-12","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2016-09-21","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}